Article Details
Retrieved on: 2022-06-05 15:32:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company also announced the recommended Phase 2 dose for alternating 2-vector HB-202/HB-201, which showed superior immune and tumor response ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here